These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 6229371)

  • 41. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
    Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH
    Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor.
    Palacios R; Alarcón-Segovia D; Llorente L; Ruíz-Arguelles A; Díaz-Jouanen E
    J Clin Lab Immunol; 1981 Mar; 5(2):71-80. PubMed ID: 6971333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
    Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
    Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monocyte disorders associated with T cell defects in patients with solid tumors.
    Anastasopoulos E; Reclos GJ; Baxevanis CN; Gritzapis AD; Tsilivakos V; Panagiotopoulos N; Fotiou S; Missitzis I; Karydas I; Papamichail M
    Anticancer Res; 1992; 12(2):489-94. PubMed ID: 1533752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytokine production in patients with systemic lupus erythematosus].
    Müzes G; González-Cabello R; Van Vien C; Fehér J; Gergely P
    Orv Hetil; 1991 Sep; 132(36):1971-4. PubMed ID: 1923468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of immune abnormalities in systemic lupus erythematosus.
    Steinberg AD; Smith HR; Laskin CA; Steinberg BJ; Smolen JS
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):101-10. PubMed ID: 6213146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
    Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
    Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormal T-cell activation in chronic hepatitis B viral infection: a consequence of monocyte dysfunction?
    Nouri-Aria KT; Magrin S; Alexander GJ; Anderson MG; Williams R; Eddleston AL
    Immunology; 1988 Aug; 64(4):733-8. PubMed ID: 2971612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of Con A-induced lymphokines from the T-lymphocyte subpopulations on human monocyte leishmanicidal capacity and H2O2 production.
    Passwell JH; Shor R; Gazit E; Shoham J
    Immunology; 1986 Oct; 59(2):245-50. PubMed ID: 2945777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.
    Llorente L; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Maillot MC; Durand-Gasselin I; Fourrier BM; Galanaud P; Emilie D
    Eur Cytokine Netw; 1993; 4(6):421-7. PubMed ID: 8186374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
    Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
    González-Amaro R; Portales-Pérez D; Baranda L; Abud-Mendoza C; Llorente L; Richaud-Patin Y; Alcocer-Varela J; Alarcón-Segovia D
    J Autoimmun; 1998 Oct; 11(5):395-402. PubMed ID: 9802922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte response.
    Baxevanis CN; Reclos GJ; Economou M; Arsenis P; Katsiyiannis A; Seferiades K; Papadopoulos G; Tsolas O; Papamichail M
    Immunopharmacol Immunotoxicol; 1988; 10(4):443-61. PubMed ID: 2977606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2.
    Takada S; Ueda Y; Suzuki N; Murakawa Y; Hoshino T; Green I; Steinberg AD; Horwitz DA; Sakane T
    Eur J Immunol; 1985 Mar; 15(3):262-7. PubMed ID: 3156746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalase.
    Wesch D; Marx S; Kabelitz D
    J Immunol; 1998 Aug; 161(3):1248-56. PubMed ID: 9686585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects.
    Via CS; Tsokos GC; Bermas B; Clerici M; Shearer GM
    J Immunol; 1993 Oct; 151(7):3914-22. PubMed ID: 8376810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.
    Gottlieb AB; Lahita RG; Chiorazzi N; Kunkel HG
    J Clin Invest; 1979 May; 63(5):885-92. PubMed ID: 312809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
    Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
    Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.